source
- Top young AI researchers avoid careers at large pharmaceutical companiesMazdak Abulnaga, a 33‑year‑old postdoctoral fellow at MIT and Harvard Medical School, is highlighted as the type of employee pharmaceutical companies hope to attract this year. Despite the demand,…
- Sevabertinib-related diarrhea in HER2-mutated NSCLC is generally low-grade and manageable, study showsThe SOHO-01 trial examined the safety of sevabertinib in patients with HER2-mutated non-small cell lung cancer, focusing on treatment-related diarrhea. Diarrhea occurred frequently but was mostly…